Evidence map›Paper›PMID 26582263›Full record

ArticleScientific reports2015

An Efficient Site-Specific Method for Irreversible Covalent Labeling of Proteins with a Fluorophore.

Jiaquan Liu, Jeungphill Hanne, Brooke M Britton, Matthew Shoffner, Aaron E Albers, Jared Bennett, Rachel Zatezalo, Robyn Barfield, David Rabuka, Jong-Bong Lee and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Chemical Conjugation to Less Targeted Proteinogenic Amino Acids.Chembiochem : a European journal of chemical biology · 2022
    Review
  2. Review
  3. Article
  4. The Pictet-Spengler Reaction Updates Its Habits.Molecules (Basel, Switzerland) · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jiaquan LiuDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
Jeungphill HanneDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
Brooke M BrittonDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
Matthew ShoffnerDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
Aaron E AlbersCatalent Biologics-West, Emeryville, CA 94608.
Jared BennettDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
Rachel ZatezaloDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
Robyn BarfieldCatalent Biologics-West, Emeryville, CA 94608.
David RabukaCatalent Biologics-West, Emeryville, CA 94608.
Jong-Bong LeeDepartment of Physics, Pohang University of Science and Technology (POSTECH), Pohang, Korea.
Richard FishelDepartment of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210.
The Ohio State University · USCatalent (United States) · USThe Ohio State University Wexner Medical Center · USPohang University of Science and Technology · KR

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The Human Mismatch Repair Proteins and CarcinogenesisR01CA067007 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI Richard Fishel · 1995 to 2026
$9.6M
Recombination/Repair Complex in Human CellsR01GM080176 · NIGMS · OHIO STATE UNIVERSITY · PI FISHEL, RICHARD · 2006 to 2015
$3.2M
NCI NIH HHS CA67007NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA067007NIGMS NIH HHS GM080176NIGMS NIH HHS R01 GM080176
6 · The paper itself

Abstract

Fluorophore labeling of proteins while preserving native functions is essential for bulk Förster resonance energy transfer (FRET) interaction and single molecule imaging analysis. Here we describe a versatile, efficient, specific, irreversible, gentle and low-cost method for labeling proteins with fluorophores that appears substantially more robust than a similar but chemically distinct procedure. The method employs the controlled enzymatic conversion of a central Cys to a reactive formylglycine (fGly) aldehyde within a six amino acid Formylglycine Generating Enzyme (FGE) recognition sequence in vitro. The fluorophore is then irreversibly linked to the fGly residue using a Hydrazinyl-Iso-Pictet-Spengler (HIPS) ligation reaction. We demonstrate the robust large-scale fluorophore labeling and purification of E.coli (Ec) mismatch repair (MMR) components. Fluorophore labeling did not alter the native functions of these MMR proteins in vitro or in singulo. Because the FGE recognition sequence is easily portable, FGE-HIPS fluorophore-labeling may be easily extended to other proteins.

Indexed as

Staining and LabelingAdenosine TriphosphateBiochemistryDNAEscherichia coliEscherichia coli ProteinsFluorescent DyesMutS DNA Mismatch-Binding ProteinAdenosine TriphosphateDNAEscherichia coli ProteinsFluorescent DyesMutS DNA Mismatch-Binding ProteinMutS protein, E coli

Identifiers

PMID26582263
PMCPMC4652282
OpenAlexW2175393769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.